TransMedics (TMDX) FCF Margin Growth (3y) (2021 - 2026)
TransMedics (TMDX) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 60.00 |
| 10 | TransMedics | 3.23 Bn | 2.76 Bn | 113.20 Mn | 1,907.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,907.00 |
| Mar 31, 2026 | 1,610.00 |
| Dec 31, 2025 | 3,349.00 |
| Sep 30, 2025 | 10,401.00 |
| Jun 30, 2025 | 12,160.00 |
| Mar 31, 2025 | 10,099.00 |
| Dec 31, 2024 | 22,651.00 |
| Sep 30, 2024 | 7,494.00 |
| Jun 30, 2024 | 12,807.00 |
| Mar 31, 2024 | 4,692.00 |
| Dec 31, 2023 | -7,755.00 |
| Sep 30, 2023 | 6,984.00 |
| Jun 30, 2023 | 20,658.00 |
| Mar 31, 2023 | 8,699.00 |
| Dec 31, 2022 | 9,950.00 |
| Sep 30, 2022 | -737.00 |
| Jun 30, 2022 | 16,645.00 |
| Mar 31, 2022 | 3,633.00 |
| Dec 31, 2021 | 6,149.00 |
| Sep 30, 2021 | -1,922.00 |